Related Experiment Videos
Hodgkin disease in a patient with common variable immunodeficiency
S M Fesus1, F B Hagemeister, J Manning
1Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
American Journal of Hematology
|October 1, 1989
Summary
A young man with common variable immunodeficiency developed extensive extralymphatic Hodgkin disease. Despite treatment, he succumbed to overwhelming infection, highlighting a rare association between primary immunodeficiency and advanced Hodgkin lymphoma.
Area of Science:
- Immunology
- Oncology
- Hematology
Background:
- Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia, recurrent infections, and autoimmune disorders.
- Hodgkin disease (HD) is a malignancy of the lymphatic system, with extralymphatic involvement indicating advanced disease.
- The interplay between primary immunodeficiencies and the development of malignancies like HD is complex and not fully understood.
Observation:
- A young male patient presented with common variable immunodeficiency (CVID), exhibiting hypogammaglobulinemia, recurrent sinopulmonary infections, and autoimmune phenomena.
- The patient subsequently developed extensive extralymphatic Hodgkin disease, indicating a rare and aggressive presentation.
- Both humoral and cell-mediated immune functions were compromised prior to therapeutic intervention.
Findings:
- The patient received two cycles of chemotherapy for extralymphatic Hodgkin disease.
- Despite prophylactic gammaglobulin replacement, the patient experienced irreversible shock and succumbed to overwhelming infection.
- This case represents a previously unreported association between extralymphatic Hodgkin disease and primary immunodeficiency.
Implications:
- This case underscores the complex relationship between primary immunodeficiencies and the risk of developing aggressive malignancies.
- The findings suggest that patients with CVID may be at increased risk for unusual presentations of Hodgkin disease.
- Further research is warranted to elucidate the mechanisms underlying this association and to inform clinical management strategies for immunocompromised patients with cancer.